Therapeutic Marine Enzyme Inhibitors as Leads for the Discovery of New Bioactive Drugs
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 October 2020) | Viewed by 5069
Special Issue Editor
Interests: synthesis; reactivity studies of policondensed nitrogen heterocycles; synthesis of marine-derived analogs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Enzyme inhibitors, which are bioactive molecules that are able to bind enzymes decreasing their bioactivity, are applied in different therapeutic areas since they are enzymes involved in the control of complex biochemical networks. Many marine natural products are enzyme inhibitors used as chemical defences in their natural environment. Considering their significant biological activity and their structural variety, they represent important lead compounds for the discovery of new molecules with therapeutic applications.
This Special Issue "Therapeutic Marine Enzyme Inhibitors as Leads for the Discovery of New Bioactive Drugs" focuses on recent advances in the isolation, synthesis, biosynthesis, and characterization of marine-derived compounds or analogs designed through an in silico or classical medicinal chemistry approach, with enzyme inhibitory activity that could be useful for the treatment of various diseases.
Dr. Barbara Parrino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Drug discovery
- Marine-derived molecule
- Marine-derived analogs
- Synthesis
- Enzyme inhibitors
- Biological activity
- Computational studies
- Therapeutic drugs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
